Publications

1. Youland RS, Khwaja SS, Schomas DA, Keating GF, Wetjen NM, Laack NN. Prognostic factors and survival patterns in pediatric low-grade gliomas over 4 decades. J Pediatr Hematol Oncol. 2013 Apr; 35(3):197-205. 2271100
   View PubMed
2. Cheville AL, Brinkmann DH, Ward SB, Durski J, Laack NN, Yan E, Schomberg PJ, Garces YI, Suman VJ, Petersen IA. The addition of SPECT/CT lymphoscintigraphy to breast cancer radiation planning spares lymph nodes critical for arm drainage. Int J Radiat Oncol Biol Phys. 2013 Mar 15; 85(4):971-7. 2308226
   View PubMed
3. Robinson SI, Ahmed SK, Okuno SH, Arndt CA, Rose PS, Laack NN. Clinical Outcomes of Adult Patients With Relapsed Ewing Sarcoma: A 30-Year Single-Institution Experience. Am J Clin Oncol. 2013 Mar 04. [Epub ahead of print] 2308708
   View PubMed
4. Pafundi DH, Laack NN, Youland RS, Parney IF, Lowe VJ, Giannini C, Kemp BJ, Grams MP, Morris JM, Hoover JM, Hu LS, Sarkaria JN, Brinkmann DH. Biopsy validation of 18F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation: results of a prospective pilot study. Neuro Oncol. 2013 Mar 03. [Epub ahead of print] 2308243
   View PubMed
5. Ahmed SK, Robinson SI, Okuno SH, Rose PS, Issa Laack NN. Adult Ewing Sarcoma: Survival and Local Control Outcomes in 36 Patients With Metastatic Disease. Am J Clin Oncol. 2013 Feb 5.. [Epub ahead of print] 2302527
   View PubMed
6. Ahmed KA, Laack NN, Eckel LJ, Orme NM, Wetjen NM. Histologically Proven, Low-grade Brainstem Gliomas in Children: 30-Year Experience With Long-term Follow-up at Mayo Clinic. Am J Clin Oncol. 2013 Jan 24. [Epub ahead of print] 2299545
   View PubMed
7. Youland RS, Kitange GJ, Peterson TE, Pafundi DH, Ramiscal JA, Pokorny JL, Giannini C, Laack NN, Parney IF, Lowe VJ, Brinkmann DH, Sarkaria JN. The role of LAT1 in (18)F-DOPA uptake in malignant gliomas. J Neurooncol. 2013 Jan; 111(1):11-8. Epub 2012 Oct 20. 2278574
   View PubMed
8. Ahmed SK, Robinson SI, Okuno SH, Rose PS, Issa Laack NN. Adult Ewing sarcoma: survival and local control outcomes in 102 patients with localized disease. Sarcoma. 2013(2013):Article ID 681425.. 2331124
   
9. Merchant TE, Hodgson D, Laack NNI, Wolden S, Indelicato DJ, Kalapurakal JA. Children's Oncology Group's 2013 blueprint for research: Radiation oncology. Pediatr Blood Cancer. 2013; 60(6):1037-43. 2320741
   
10. Youland RS, Kitange GJ, Peterson TE, Pafundi DH, Ramiscal JA, Pokorny JL, Giannini C, Laack NN, Parney IF, Lowe VJ, Brinkmann DH, Sarkaria JN. The role of LAT1 in 18F-DOPA uptake in malignant gliomas. J Neurooncol. 2013; 111(1):11-8. 2297349
    
11. Compton JJ, Laack NN, Eckel LJ, Schomas DA, Giannini C, Meyer FB. Long-term outcomes for low-grade intracranial ganglioglioma: 30-year experience from the Mayo Clinic. J Neurosurg. 2012 Nov; 117(5):825-30. Epub 2012 Sep 7. 2326518
    View PubMed
12. Call JA, Naik M, Rodriguez FJ, Giannini C, Wu W, Buckner JC, Parney IF, Laack NN. Long-term Outcomes and Role of Chemotherapy in Adults With Newly Diagnosed Medulloblastoma. Am J Clin Oncol. 2012 Oct 29. [Epub ahead of print] 2280762
    View PubMed
13. Youland RS, Brown PD, Giannini C, Parney IF, Uhm JH, Laack NN. Adult Low-grade Glioma: 19-year Experience at a Single Institution. Am J Clin Oncol. 2012 Aug 13. [Epub ahead of print] 2264433
    View PubMed
14. Ahmed KA, Barney BM, Macdonald OK, Miller RC, Garces YI, Laack NN, Haddock MG, Foote RL, Olivier KR. Stereotactic Body Radiotherapy in the Treatment of Adrenal Metastases. Am J Clin Oncol. 2012 Jul 09. [Epub ahead of print] 2257049
    View PubMed
15. Arndt CA, Rose PS, Folpe AL, Laack NN. Common musculoskeletal tumors of childhood and adolescence. Mayo Clin Proc. 2012 May; 87(5):475-87. 2243859
    View PubMed
16. Caine C, Mehta MP, Laack NN, Gondi V. Cognitive function testing in adult brain tumor trials: lessons from a comprehensive review. Expert Rev Anticancer Ther. 2012 May; 12(5):655-67. 2253320
    View PubMed
17. Ahmed KA, Stauder MC, Miller RC, Bauer HJ, Rose PS, Olivier KR, Brown PD, Brinkmann DH, Laack NN. Stereotactic body radiation therapy in spinal metastases. Int J Radiat Oncol Biol Phys. 2012 Apr 1; 82(5):e803-9. Epub 2012 Feb 11. 2224242
    View PubMed
18. Bram RJ, Laack NNI. Protons: Moving therapy for hodgkin lymphoma in a positive direction. ONCOLOGY (United States). 2012; 26(5). 2313473
    
19. Foote RL, Stafford SL, Petersen IA, Pulido JS, Clarke MJ, Schild SE, Garces YI, Olivier KR, Miller RC, Haddock MG, Yan E, Laack NN, Arndt CA, Buskirk SJ, Miller VL, Brent CR, Kruse JJ, Ezzell GA, Herman MG, Gunderson LL, Erlichman C, Diasio RB. The clinical case for proton beam therapy. Radiat Oncol. 2012; 7:174. Epub 2012 Oct 22. 2287846
    View PubMed
20. Laack NN, O'Neill BP, Ballman KV, O'Fallon JR, Carrero XW, Kurtin PJ, Scheithauer BW, Brown PD, Habermann TM, Colgan JP, Gilbert MR, Hawkins RB, Morton RF, Windschitl HE, Fitch TR, Pajon ER Jr, North Central Cancer Treatment Group and Mayo Clinic. CHOD/BVAM chemotherapy and whole-brain radiotherapy for newly diagnosed primary central nervous system lymphoma. Int J Radiat Oncol Biol Phys. 2011 Oct 1; 81(2):476-82. Epub 2010 Aug 26. 2213883
    View PubMed
21. Stauder MC, Laack NN, Moir CR, Schomberg PJ. Excellent local control and survival after intraoperative and external beam radiotherapy for pediatric solid tumors: long-term follow-up of the Mayo Clinic experience. J Pediatr Hematol Oncol. 2011 Jul; 33(5):350-5. 2166803
    View PubMed
22. Laack TA, Thompson KM, Kofler JM, Bellolio MF, Sawyer MD, Laack NN. Comparison of trauma mortality and estimated cancer mortality from computed tomography during initial evaluation of intermediate-risk trauma patients. J Trauma. 2011 Jun; 70(6):1362-5. 2192276
    View PubMed
23. Jensen AW, Laack NN, Buckner JC, Schomberg PJ, Wetmore CJ, Brown PD. Long-term follow-up of dose-adapted and reduced-field radiotherapy with or without chemotherapy for central nervous system germinoma. Int J Radiat Oncol Biol Phys. 2010 Aug 1; 77(5):1449-56. Epub 2010 Jan 04. 2106803
    View PubMed
24. Rao AA, Laack NN, Giannini C, Wetmore C. Pleomorphic xanthoastrocytoma in children and adolescents. Pediatr Blood Cancer. 2010 Aug; 55(2):290-4. 2103384
    View PubMed
25. Schomas DA, Laack NN, Brown PD. Low-grade gliomas in older patients: long-term follow-up from Mayo Clinic. Cancer. 2009 Sep 1; 115(17):3969-78. 1949851
    View PubMed
26. Schomas DA, Laack NN, Rao RD, Meyer FB, Shaw EG, O'Neill BP, Giannini C, Brown PD. Intracranial low-grade gliomas in adults: 30-year experience with long-term follow-up at Mayo Clinic. Neuro Oncol. 2009 Aug; 11(4):437-45. Epub 2008 Nov 18. 1915354
    View PubMed
27. Loprinzi CL, Wolf SL, Barton DL, Laack NN. Symptom management in premenopausal patients with breast cancer. Lancet Oncol. 2008 Oct; 9(10):993-1001. 1909961
    View PubMed
28. Bakkum-Gamez JN, Gonzalez-Bosquet J, Laack NN, Mariani A, Dowdy SC. Current issues in the management of endometrial cancer. Mayo Clin Proc. 2008 Jan; 83(1):97-112. 1867485
    View PubMed
29. Long HJ 3rd, Laack NN, Gostout BS. Prevention, diagnosis, and treatment of cervical cancer. Mayo Clin Proc. 2007 Dec; 82(12):1566-74. 1859042
    View PubMed
30. Laack NN, Ballman KV, Brown PB, O'Neill BP, North Central Cancer Treatment Group. Whole-brain radiotherapy and high-dose methylprednisolone for elderly patients with primary central nervous system lymphoma: Results of North Central Cancer Treatment Group (NCCTG) 96-73-51. Int J Radiat Oncol Biol Phys. 2006 Aug 1; 65(5):1429-39. 1775789
    View PubMed
31. Laack NN, Brown PD, Ivnik RJ, Furth AF, Ballman KV, Hammack JE, Arusell RM, Shaw EG, Buckner JC. Cognitive function after radiotherapy for supratentorial low-grade glioma: A North Central Cancer Treatment Group prospective study. Int J Radiat Oncol Biol Phys. 2005 Nov 15; 63(4):1175-83. 1996799
    
32. Laack NN, Brown PD. Cognitive sequelae of brain radiation on adults. Semin Oncol. 2004 Oct; 31(5):702-13. 1673777
    View PubMed
33. De Leon DD, Issa N, Nainani S, Asmerom Y. Reversal of cathepsin D routing modulation in MCF-7 breast cancer cells expressing antisense insulin-like growth factor II (IGF-II). Horm Metab Res. 1999 Feb-Mar; 31(2-3):142-7. 1768368
    View PubMed